Urinary metabolites of felodipine, a new vasodilator drug, in man, dog, rat and mouse
- 1 January 1984
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 14 (8) , 657-666
- https://doi.org/10.3109/00498258409151463
Abstract
1. The urinary excretion of total 14C after oral administration of 25 mg (∼ 1 μmol/kg) 14C-felodipine to man, and intragastric administration (5 μmol/kg) to dog, rat and mouse, was 70, 39, 44 and 53% dose, respectively, in 72 h. 2. Metabolites of felodipine were separated and quantified by h.p.l.c. Unchanged felodipine and its oxidized analogue were not excreted by any of the species studies. 3. Three metabolites, present in all species studied, were isolated from urine and identified as products of the oxidation of felodipine to its pyridine analogue followed by hydrolysis of one or both of the pyridine carboxylic acid esters.This publication has 6 references indexed in Scilit:
- Felodipine ? A new vasodilator, in addition to ?-receptor blockade in hypertensionEuropean Journal of Clinical Pharmacology, 1983
- Haemodynamic effects of a new vasodilator drug, felodipine, in healthy subjectsEuropean Journal of Clinical Pharmacology, 1983
- Identification of nifedipine metabolites and their determination by gas chromatography.CHEMICAL & PHARMACEUTICAL BULLETIN, 1980
- Absorption, Excretion and Metabolism of a New Dihydropyridine Diester Cerebral Vasodilator in Rats and DogsXenobiotica, 1977
- Metabolism of the Antihypertensive Agent 1,4-Dihydro-2,6-dimethyl-4-(2-trifluoromethylphenyl)-3,5-pyridinedicarboxylic Acid Diethyl EsterJournal of Pharmaceutical Sciences, 1973
- Biotransformation of 1,4-dihydro-2,6-dimethyl-4-(2-trifluoromethylphenyl)-3,5-pyridinedicarboxylic acid diethyl esterJournal of Medicinal Chemistry, 1973